SCHEMBL16474346

SCHEMBL16474346

CCOC(=O)c1cc(OC(C)=O)c2ccc([N+](=O)[O-])cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 6/20 0.47
HTT P42858 1/20 0.44
MAOB P27338 1/20 0.44
ELANE P08246 2/20 0.43
PDE7A Q13946 1/20 0.43
KMT2A Q03164 3/20 0.42
TP53 P04637 2/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 2/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11124197 0.91 MAPT (0.49) NPC1SMN1; SMN2MAPTHTTMAOB
SCHEMBL3330717 0.83 BCL2L1 (0.45) NPC1SMN1; SMN2MAPTMAOBTP53
SCHEMBL16479442 0.82 ALDH1A1 (0.54) NPC1SMN1; SMN2MAPTKMT2ATP53
SCHEMBL13005288 0.81 ALDH1A1 (0.43) NPC1SMN1; SMN2MAPTHTTELANE
SCHEMBL16474350 0.81 LMNA (0.50) NPC1SMN1; SMN2MAPTELANEKMT2A
SCHEMBL2807973 0.81 TSHR (0.45) NPC1SMN1; SMN2MAPTELANEKMT2A
SCHEMBL3328123 0.79 HTT (0.48) NPC1SMN1; SMN2MAPTHTTKMT2A
SCHEMBL11124333 0.77 MEN1 (0.55) NPC1SMN1; SMN2MAPTHTTKMT2A
SCHEMBL11124330 0.76 NPC1 (0.53) NPC1SMN1; SMN2MAPTMAOBELANE
Acetic Acid SCHEMBL11124229 0.75 MAPT (0.50) NPC1SMN1; SMN2MAPTMAOBELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 NPC1 2498/4885SMN1; SMN2 3498/4885MAPT 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.